A clear rise in coronavirus cases in Germany | DW Arabic news | Breaking news and perspectives from around the world | DW

A clear rise in coronavirus cases in Germany | DW Arabic news | Breaking news and perspectives from around the world | DW
A clear rise in coronavirus cases in Germany | DW Arabic news | Breaking news and perspectives from around the world | DW

1976, the German Robert Koch Institute announced this Thursday morning (October 28, 2021) a clear increase in the weekly infection rate with the emerging corona virus.

Today, the institute indicated that this rate, which is the number of infections per 130.2, was 118 yesterday, Wednesday, and this rate was 85.6 a week ago.

Today, the institute added that health offices in Germany recorded a total of 28,037 new cases of the virus within 24 hours, as well as 126 deaths.

It is reported that 16,077 cases of the virus were recorded one week ago, as well as 67 deaths.

The lowest rate was recorded on July 6, at 4.9 injuries, while the highest rate was recorded on December 22, with 197.6 injuries. According to the institute’s data, the number of cases of HIV infection since its outbreak in Germany in the spring of last year has reached four million and 534 thousand and 452 cases.

But the institute indicated that the actual total number of cases may be much higher. Since many cases of infection have not been discovered and recorded.

Today, Thursday, the institute added that the total number of people recovering from infection with the virus reached four million and 247 thousand people, while the number of people who died as a result of infection or its consequences reached 95 thousand and 485 people.

The number of Corona patients receiving treatment in intensive care units rose to 1,761 yesterday, Wednesday. Some of them are not attached to the Corona virus.

H.D./WB (DPA, Reuters)

  • Different nationalities.. Learn about the most famous licensed vaccines around the world

    Biontech/Pfizer Vaccine

    Developed by German Piontech jointly with American Pfizer. Its effectiveness, according to the latest clinical trials, is 95 percent. It is the first vaccine against corona approved by the World Health Organization. It is based on mRNA technology, and is the most widely used vaccine in the Western world, but it has been criticized for the difficulty of storing it, as it needs to minus 70 degrees Celsius to maintain its effectiveness.

  • Different nationalities.. Learn about the most famous licensed vaccines around the world

    Moderna

    The second vaccine to be licensed by the European Union after Pfizer/Biontech. Developed by the American company Moderna in cooperation with the US National Institutes of Health for Infectious Diseases. Its effectiveness has reached 95 percent. It adopts almost the same technology (mRNA), but its storage conditions are less stringent and it needs minus 20 degrees. Despite this, the quantities of its distribution in the world remained less than the first vaccine, which may be explained by its price of $ 33 per dose, unlike the second vaccine of $ 20.

  • Different nationalities.. Learn about the most famous licensed vaccines around the world

    Sputnik V

    It is the first vaccine in the world whose developers announce its effectiveness against Corona, even though it had not yet passed the third stage. It was developed by the Russian State Aesthetic Institute, and its effectiveness reaches 92 percent, according to Russian figures, but with Western scientific hesitation due to the lack of published data about it. It was imported by several countries, including Hungary, Algeria, Serbia and the UAE. It’s easy to transport and cheap ($10) and uses adenovirus (or adenovirus) vector technology.

  • Different nationalities.. Learn about the most famous licensed vaccines around the world

    AstraZeneca/Oxford

    The second vaccine authorized by the World Health Organization and the third for the European Union. The cheapest vaccines, but also the least effective (70 percent), and many countries questioned its effectiveness against the elderly, as well as against mutated versions. Developed by the British-Swedish company AstraZeneca in cooperation with the University of Oxford. It was imported by several countries after the contribution of the Serum Institute of India to its production. It is easy to transport and store and it also uses glandular conveyor technology.

  • Different nationalities.. Learn about the most famous licensed vaccines around the world

    Sinopharm

    Developed by China’s state-owned Sinopharm with Beijing Institute of Biological Products. It was first introduced by the UAE before being licensed by China, and then it was imported by several countries, including Morocco, Jordan and Egypt. Its effectiveness rate, according to its manufacturers, reached 79 percent, but the scientific data is not published properly. It uses the inactivated virus injection technique, and the biggest mystery surrounding it is its price, as several reports stated that the dose is not less than $ 30, while others mentioned a lower or higher price.

  • Different nationalities.. Learn about the most famous licensed vaccines around the world

    Coronavac

    It was produced by the Chinese company Sinovac, but licensing it in China took longer. Its effectiveness is controversial, as tests in Brazil showed that it did not exceed 51 percent, but other tests in Turkey, which was among the first to license it, raised the effectiveness to 91 percent. He uses the same technology as the Sinopharma vaccine, and many questions surround him due to the lack of data, especially its price, which has not been reported, although reports have estimated it at ten dollars.

  • Different nationalities.. Learn about the most famous licensed vaccines around the world

    Johnson & Johnson

    It was developed by the American company “Johnson & Johnson”, and South Africa began using it, although it was not licensed in the United States or Europe, after it was found that it was able to confront the mutated version, contrary to what was shown by first experiments. Its effectiveness is estimated at 66 percent globally and 72 in America. It is distinguished from others that it is from a single dose, which strengthens its chances of spreading even more. It uses adenovirus vector technology, and is easy to store.

Source

clear rise coronavirus cases Germany Arabic news Breaking news perspectives world

 
For Latest Updates Follow us on Google News
 

PREV 50 thousand injuries in Germany: the next government in the face of Corona! | DW Arabic news | Breaking news and perspectives from around the world | DW
NEXT The Ministry of Health authorizes the emergency use of the “Pfizer-Biontech” Covid-19 vaccine for the age group from 5 to 11 years